Advertisement
Clinical Science| Volume 62, ISSUE 6, P814-819, June 2013

Maternal serum retinol-binding protein-4 at 11–13weeks’ gestation in normal and pathological pregnancies

Published:February 13, 2013DOI:https://doi.org/10.1016/j.metabol.2012.12.011

      Abstract

      Objective

      To examine maternal serum levels of retinol-binding protein-4 (RBP4) at 11–13 weeks’ gestation in normal and pathological pregnancies.

      Methods

      Serum RBP4 at 11–13 weeks was measured in 480 singleton pregnancies, including 240 with normal outcome, 60 that subsequently developed preeclampsia (PE), 60 that developed gestational diabetes mellitus (GDM), 60 that delivered large for gestational age (LGA) neonates and 60 that delivered small (SGA) neonates. The values in each adverse pregnancy outcome group were compared to those of normal pregnancies.

      Results

      Serum concentration of RBP4 was not significantly different in women who subsequently developed PE (p=0.925), or GDM (p=0.074), or had pregnancies that led to delivery to SGA (p=0.085), LGA (p=0.332) neonates.

      Conclusion

      Maternal serum RBP4 in the first trimester is not significantly altered in pathological pregnancies.

      Abbreviations:

      AGA (Appropriate for gestational age), β-HCG (β-Human Chorionic Gonadotrophin), CRL (Crown-rump length), CV (Coefficient of Variation), ELISA (Enzyme-linked Immunosorbent Assay), EIA (Enzyme Immunometric Assay), GDM (Gestational Diabetes Mellitus), LGA (Large for gestational age), MoM (Multiples of Median), NT (Nuchal Translucency), PAPP-A (Pregnancy-associated Plasma Protein A), PE (Preeclampsia), RBP4 (Retinol binding protein-4), SGA (Small for gestational age), T2DM (Type 2 diabetes mellitus)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Blaner W.S.
        Retinol-binding protein: the serum transport protein for vitamin A.
        Endocr Rev. 1989; 10: 308-316
        • Tsutsumi C.
        • Okuno M.
        • Tannous L.
        • et al.
        Retinoids and retinoid-binding protein expression in rat adipocytes.
        J Biol Chem. 1992; 267: 1805-1810
        • Yang Q.
        • Graham T.E.
        • Mody N.
        • et al.
        Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
        Nature. 2005; 21: 352-356
        • Yao-Borengasser A.
        • Varma V.
        • Bodles A.M.
        • et al.
        Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.
        J Clin Endocrinol Metab. 2007; 92: 2590-2597
        • Graham T.E.
        • Yang Q.
        • Blüher M.
        • et al.
        Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
        N Engl J Med. 2006; 354: 2552-2563
        • Lin C.C.
        • Lai M.M.
        • Li T.C.
        • et al.
        Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome.
        Diabetes Res Clin Pract. 2009; 85: 24-29
        • Solini A.
        • Santini E.
        • Madec S.
        • et al.
        Retinol-binding protein-4 in women with untreated essential hypertension.
        Am J Hypertens. 2009; 22: 1001-1006
        • Olszanecka-Glinianowicz M.
        • Madej P.
        • Zdun D.
        • et al.
        Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?.
        Eur J Obstet Gynecol Reprod Biol. 2012; 162: 55-61
        • Koch A.
        • Weiskirchen R.
        • Sanson E.
        • et al.
        Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation.
        Crit Care. 2010; 14: R179
        • Bujold E.
        • Romero R.
        • Kusanovic J.P.
        • et al.
        Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry.
        J Matern Fetal Neonatal Med. 2008; 21: 697-713
        • Inoue S.
        • Takamoto N.
        • Akahori Y.
        • et al.
        Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension.
        J Obstet Gynaecol Res. 2009; 35: 293-300
        • Shangguan X.
        • Liu F.
        • Wang H.
        • et al.
        Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia.
        Clin Chim Acta. 2009; 407: 58-61
        • Stepan H.
        • Ebert T.
        • Schrey S.
        • et al.
        Preliminary report: serum levels of retinol-binding protein 4 in preeclampsia.
        Metabolism. 2009; 58: 275-277
        • Vaisbuch E.
        • Romero R.
        • Mazaki-Tovi S.
        • et al.
        Retinol binding protein 4- a novel association with early-onset preeclampsia.
        J Perinat Med. 2010; 38: 129-139
        • Masuyama H.
        • Inoue S.
        • Hiramatsu Y.
        Retinol-binding protein 4 and insulin resistance in preeclampsia.
        Endocr J. 2011; 58: 47-53
        • Seol H.J.
        • Kim J.W.
        • Kim H.J.
        Retinol-binding protein-4 is decreased in patients with preeclampsia in comparison with normal pregnant women.
        J Perinat Med. 2011; 39: 287-289
        • Chan T.F.
        • Chen H.S.
        • Chen Y.C.
        • et al.
        Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus.
        Reprod Sci. 2007; 14: 169-174
        • Kim S.H.
        • Choi H.J.
        • Im J.A.
        Retinol-binding protein 4 responses during an oral glucose tolerance testing in women with gestational diabetes mellitus.
        Clin Chim Acta. 2008; 391: 123-125
        • Krzyzanowska K.
        • Zemany L.
        • Krugluger W.
        • et al.
        Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes.
        Diabetologia. 2008; 51: 1115-1122
        • Lewandowski K.C.
        • Stojanovic N.
        • Bienkiewicz M.
        • et al.
        Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1).
        Gynecol Endocrinol. 2008; 24: 300-305
        • Klein K.
        • Bancher-Todesca D.
        • Leipold H.
        • et al.
        Retinol-binding protein 4 in patients with gestational diabetes mellitus.
        J Womens Health (Larchmt). 2010; 19: 517-521
        • Maghbooli Z.
        • Hossein-Nezhad A.
        • Mirzaei K.
        • et al.
        Association between retinol-binding protein 4 concentrations and gestational diabetes mellitus and risk of developing metabolic syndrome after pregnancy.
        Reprod Sci. 2010; 17: 196-201
        • Su Y.X.
        • Hong J.
        • Yan Q.
        • et al.
        Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitus.
        Diabetes Metab. 2010; 36: 470-475
        • Tepper B.J.
        • Kim Y.K.
        • Shete V.
        • et al.
        Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes.
        Clin Biochem. 2010; 43: 320-323
        • Kuzmicki M.
        • Telejko B.
        • Wawrusiewicz-Kurylonek N.
        • et al.
        Retinol-binding protein 4 in adipose and placental tissue of women with gestational diabetes.
        Gynecol Endocrinol. 2011; 27: 1065-1069
        • Khovidhunkit W.
        • Pruksakorn P.
        • Plengpanich W.
        • et al.
        Retinol-binding protein 4 is not associated with insulin resistance in pregnancy.
        Metabolism. 2012; 6: 65-69
        • Mazaki-Tovi S.
        • Romero R.
        • Vaisbuch E.
        • et al.
        Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus.
        J Perinat Med. 2010; 38: 147-155
        • Snijders R.J.
        • Noble P.
        • Sebire N.
        • et al.
        UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation.
        Lancet. 1998; 352: 343-346
        • Kagan K.O.
        • Wright D.
        • Baker A.
        • et al.
        Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A.
        Ultrasound Obstet Gynecol. 2008; 31: 618-624
        • Plasencia W.
        • Maiz N.
        • Bonino S.
        • et al.
        Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of preeclampsia.
        Ultrasound Obstet Gynecol. 2007; 30: 742-749
        • Poon L.C.
        • Karagiannis G.
        • Staboulidou I.
        • et al.
        Reference range of birth weight with gestation and first-trimester prediction of small for gestation neonates.
        Prenat Diagn. 2011; 31: 58-65
        • Brown M.A.
        • Lindheimer M.D.
        • de Swiet M.
        • et al.
        The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).
        Hypertens Pregnancy. 2001; 20: IX-XIV
      1. World Health Organisation: definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia; report of a WHO/IDF consultation 2006;1–46 (accessed July 2012 at http://www.who.int/diabetes/publications/en/).

        • Laudes M.
        • Oberhauser F.
        • Bilkovski R.
        • et al.
        Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity.
        Exp Clin Endocrinol Diabetes. 2009; 117: 146-149
        • Klöting N.
        • Graham T.E.
        • Berndt J.
        • et al.
        Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.
        Cell Metab. 2007; 6: 79-87
        • Park H.
        • Green M.H.
        • Shaffer M.L.
        Association between serum retinol-binding protein 4 concentrations and clinical indices in subjects with type 2 diabetes: a meta-analysis.
        J Hum Nutr Diet. 2012; 25: 300-310
        • Kotnik P.
        • Fischer-Posovszky P.
        • Wabitsch M.
        RBP4: a controversial adipokine.
        Eur J Endocrinol. 2011; 165: 703-711
        • Gómez-Ambrosi J.
        • Rodríguez A.
        • Catalán V.
        • et al.
        Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
        Clin Endocrinol (Oxf). 2008; 69: 208-215
        • Christou G.A.
        • Tselepis A.D.
        • Kiortsis D.N.
        The metabolic role of retinol binding protein 4: an update.
        Horm Metab Res. 2012; 44: 6-14
        • Ueland T.
        • Dalsoren T.
        • Voldner N.
        • et al.
        Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies.
        Eur J Endocrinol. 2008; 159: 49-54
        • D'Anna R.
        • Baviera G.
        • Corrado F.
        • et al.
        Adiponectin and insulin resistance in early- and late-onset preeclampsia.
        BJOG. 2006; 113: 1264-1269
        • Lewis J.G.
        • Shand B.I.
        • Elder P.A.
        • et al.
        Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance.
        Diabetes Res Clin Pract. 2008; 80: e13-e15
        • Giacomozzi C.
        • Ghirri P.
        • Lapolla R.
        • et al.
        Retinol-binding protein 4 in neonates born small for gestational age.
        J Endocrinol Invest. 2010; 33: 218-221
        • Chan T.F.
        • Tsai Y.C.
        • Wu C.H.
        • et al.
        The positive correlation between cord serum retinol-binding protein 4 concentrations and fetal growth.
        Gynecol Obstet Invest. 2011; 72: 98-102
        • Sensi M.
        • Bruno M.R.
        • Valente L.
        • Cioccia G.P.
        • Chianelli M.
        • Pozzilli P.
        Retinol binding protein: a short half life determinant of protein non enzymatic glycation in diabetes.
        Diabetes Res. 1990; 13: 195-198